Machine learning applications in cancer prognosis and prediction

Computational and Structural Biotechnology Journal

Volumn 13, Issue , 2015, Pages 8-17

  Kourou, Konstantina ^a   Exarchos, Themis P ^a,b   Exarchos, Konstantinos P ^a   Karamouzis, Michalis V ^c   Fotiadis, Dimitrios I ^a,b  

^a UNIVERSITY OF IOANNINA   (Greece)

^b INSTITUTE OF COMPUTER SCIENCE   (Greece)

^c UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

Cancer recurrence; Cancer survival; Cancer susceptibility; Machine learning; Predictive models

Indexed keywords

CANCER DIAGNOSIS; CANCER GROWTH; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER RESEARCH; CANCER RISK; CANCER SURVIVAL; CANCER SUSCEPTIBILITY; HUMAN; MACHINE LEARNING; MALIGNANT NEOPLASTIC DISEASE; OUTCOME ASSESSMENT; PREDICTION; PRIORITY JOURNAL; REVIEW;

EID: 84942612935     PISSN: None     EISSN: 20010370     Source Type: Journal    
DOI: 10.1016/j.csbj.2014.11.005     Document Type: Review

References (71)

1. D. Hanahan, and R.A. Weinberg Hallmarks of cancer: the next generation Cell 144 2011 646 674
2. M.-Y.C. Polley, B. Freidlin, E.L. Korn, B.A. Conley, J.S. Abrams, and L.M. McShane Statistical and practical considerations for clinical evaluation of predictive biomarkers J Natl Cancer Inst 105 2013 1677 1683
3. J.A. Cruz, and D.S. Wishart Applications of machine learning in cancer prediction and prognosis Cancer Informat 2 2006 59
4. O. Fortunato, M. Boeri, C. Verri, D. Conte, M. Mensah, P. Suatoni, and et al. Assessment of circulating microRNAs in plasma of lung cancer patients Molecules 19 2014 3038 3054
5. H.M. Heneghan, N. Miller, and M.J. Kerin MiRNAs as biomarkers and therapeutic targets in cancer Curr Opin Pharmacol 10 2010 543 550
6. D. Madhavan, K. Cuk, B. Burwinkel, and R. Yang Cancer diagnosis and prognosis decoded by blood-based circulating microRNA signatures Front Genet 4 2013
7. K. Zen, and C.Y. Zhang Circulating microRNAs: a novel class of biomarkers to diagnose and monitor human cancers Med Res Rev 32 2012 326 348
8. S. Koscielny Why most gene expression signatures of tumors have not been useful in the clinic Sci Transl Med 2 2010 [14 ps12-14 ps12]
9. S. Michiels, S. Koscielny, and C. Hill Prediction of cancer outcome with microarrays: a multiple random validation strategy Lancet 365 2005 488 492
10. C.M. Bishop Pattern recognition and machine learning 2006 Springer New York
11. T.M. Mitchell The discipline of machine learning: Carnegie Mellon University 2006 Carnegie Mellon University, School of Computer Science, Machine Learning Department
12. I.H. Witten, and E. Frank Data mining: practical machine learning tools and techniques 2005 Morgan Kaufmann
13. A. Niknejad, and D. Petrovic Introduction to computational intelligence techniques and areas of their applications in medicine Med Appl Artif Intell 51 2013
14. T. Pang-Ning, M. Steinbach, and V. Kumar Introduction to data mining 2006
15. Y. Drier, and E. Domany Do two machine-learning based prognostic signatures for breast cancer capture the same biological processes? PLoS One 6 2011 e17795
16. A. Dupuy, and R.M. Simon Critical review of published microarray studies for cancer outcome and guidelines on statistical analysis and reporting J Natl Cancer Inst 99 2007 147 157
17. L. Ein-Dor, I. Kela, G. Getz, D. Givol, and E. Domany Outcome signature genes in breast cancer: is there a unique set? Bioinformatics 21 2005 171 178
18. L. Ein-Dor, O. Zuk, and E. Domany Thousands of samples are needed to generate a robust gene list for predicting outcome in cancer Proc Natl Acad Sci 103 2006 5923 5928
19. T. Ayer, O. Alagoz, J. Chhatwal, J.W. Shavlik, C.E. Kahn, and E.S. Burnside Breast cancer risk estimation with artificial neural networks revisited Cancer 116 2010 3310 3321
20. J.C. Platt, N. Cristianini, and J. Shawe-Taylor Large margin DAGs for multiclass classification 1999 547 553
21. S. Adams Is Coursera the beginning of the end for traditional higher education? 2012 Higher Education
22. D. Cicchetti Neural networks and diagnosis in the clinical laboratory: state of the art Clin Chem 38 1992 9 10
23. A.J. Cochran Prediction of outcome for patients with cutaneous melanoma Pigment Cell Res 10 1997 162 167
24. K.P. Exarchos, Y. Goletsis, and D.I. Fotiadis Multiparametric decision support system for the prediction of oral cancer reoccurrence IEEE Trans Inf Technol Biomed 16 2012 1127 1134
25. I. Kononenko Machine learning for medical diagnosis: history, state of the art and perspective Artif Intell Med 23 2001 89 109
26. K. Park, A. Ali, D. Kim, Y. An, M. Kim, and H. Shin Robust predictive model for evaluating breast cancer survivability Engl Appl Artif Intell 26 2013 2194 2205
27. Y. Sun, S. Goodison, J. Li, L. Liu, and W. Farmerie Improved breast cancer prognosis through the combination of clinical and genetic markers Bioinformatics 23 2007 30 37
28. L. Bottaci, P.J. Drew, J.E. Hartley, M.B. Hadfield, R. Farouk, P.WR. Lee, and et al. Artificial neural networks applied to outcome prediction for colorectal cancer patients in separate institutions Lancet 350 1997 469 472
29. P.S. Maclin, J. Dempsey, J. Brooks, and J. Rand Using neural networks to diagnose cancer J Med Syst 15 1991 11 19
30. R.J. Simes Treatment selection for cancer patients: application of statistical decision theory to the treatment of advanced ovarian cancer J Chronic Dis 38 1985 171 186
31. M.F. Akay Support vector machines combined with feature selection for breast cancer diagnosis Expert Syst Appl 36 2009 3240 3247
32. S.-W. Chang, S. Abdul-Kareem, A.F. Merican, and R.B. Zain Oral cancer prognosis based on clinicopathologic and genomic markers using a hybrid of feature selection and machine learning methods BMC Bioinforma 14 2013 170
33. L.-Y. Chuang, K.-C. Wu, H.-W. Chang, and C.-H. Yang Support vector machine-based prediction for oral cancer using four snps in DNA repair genes 2011 16 18
34. A.T. Eshlaghy, A. Poorebrahimi, M. Ebrahimi, A.R. Razavi, and L.G. Ahmad Using three machine learning techniques for predicting breast cancer recurrence J Health Med Inform 4 2013 124
35. K.P. Exarchos, Y. Goletsis, and D.I. Fotiadis A multiscale and multiparametric approach for modeling the progression of oral cancer BMC Med Inform Decis Mak 12 2012 136
36. J. Kim, and H. Shin Breast cancer survivability prediction using labeled, unlabeled, and pseudo-labeled patient data J Am Med Inform Assoc 20 2013 613 618
37. L.P. Fielding, C.M. Fenoglio-Preiser, and L.S. Freedman The future of prognostic factors in outcome prediction for patients with cancer Cancer 70 1992 2367 2377
38. P.B. Bach, M.W. Kattan, M.D. Thornquist, M.G. Kris, R.C. Tate, M.J. Barnett, and et al. Variations in lung cancer risk among smokers J Natl Cancer Inst 95 2003 470 478
39. S.M. Domchek, A. Eisen, K. Calzone, J. Stopfer, A. Blackwood, and B.L. Weber Application of breast cancer risk prediction models in clinical practice J Clin Oncol 21 2003 593 601
40. F. Gascon, M. Valle, R. Martos, M. Zafra, R. Morales, and M.A. Castano Childhood obesity and hormonal abnormalities associated with cancer risk Eur J Cancer Prev 13 2004 193 197
41. X. Ren, Y. Wang, L. Chen, X.-S. Zhang, and Q. Jin ellipsoidFN: a tool for identifying a heterogeneous set of cancer biomarkers based on gene expressions Nucleic Acids Res 41 2013 e53
42. X. Ren, Y. Wang, X.-S. Zhang, and Q. Jin iPcc: a novel feature extraction method for accurate disease class discovery and prediction Nucleic Acids Res 2013 gkt343
43. Y. Wang, Q.-F. Wu, C. Chen, L.-Y. Wu, X.-Z. Yan, S.-G. Yu, and et al. Revealing metabolite biomarkers for acupuncture treatment by linear programming based feature selection BMC Syst Biol 6 2012 S15
44. M. Waddell, D. Page, and J. Shaughnessy Jr. Predicting cancer susceptibility from single-nucleotide polymorphism data: a case study in multiple myeloma ACM 2005 21 28
45. J. Listgarten, S. Damaraju, B. Poulin, L. Cook, J. Dufour, A. Driga, and et al. Predictive models for breast cancer susceptibility from multiple single nucleotide polymorphisms Clin Cancer Res 10 2004 2725 2737
46. A. Stojadinovic, A. Nissan, J. Eberhardt, T.C. Chua, J.O.W Pelz, and J. Esquivel Development of a Bayesian belief network model for personalized prognostic risk assessment in colon carcinomatosis Am Surg 77 2011 221 230
47. W. Kim, K.S. Kim, J.E. Lee, D.-Y. Noh, S.-W. Kim, Y.S. Jung, and et al. Development of novel breast cancer recurrence prediction model using support vector machine J Breast Cancer 15 2012 230 238
48. C. Park, J. Ahn, H. Kim, and S. Park Integrative gene network construction to analyze cancer recurrence using semi-supervised learning PLoS One 9 2014 e86309
49. C.-J. Tseng, C.-J. Lu, C.-C. Chang, and G.-D. Chen Application of machine learning to predict the recurrence-proneness for cervical cancer Neural Comput & Applic 24 2014 1311 1316
50. Y.-C. Chen, W.-C. Ke, and H.-W. Chiu Risk classification of cancer survival using ANN with gene expression data from multiple laboratories Comput Biol Med 48 2014 1 7
51. X. Xu, Y. Zhang, L. Zou, M. Wang, and A. Li A gene signature for breast cancer prognosis using support vector machine IEEE 2012 928 931
52. O. Gevaert, F. De Smet, D. Timmerman, Y. Moreau, and B. De Moor Predicting the prognosis of breast cancer by integrating clinical and microarray data with Bayesian networks Bioinformatics 22 2006 e184 e190
53. P. Rosado, P. Lequerica-Fernández, L. Villallaín, I. Peña, F. Sanchez-Lasheras, and J.C. de Vicente Survival model in oral squamous cell carcinoma based on clinicopathological parameters, molecular markers and support vector machines Expert Syst Appl 40 2013 4770 4776
54. D. Delen, G. Walker, and A. Kadam Predicting breast cancer survivability: a comparison of three data mining methods Artif Intell Med 34 2005 113 127
55. R.J. Urbanowicz, A.S. Andrew, M.R. Karagas, and J.H. Moore Role of genetic heterogeneity and epistasis in bladder cancer susceptibility and outcome: a learning classifier system approach J Am Med Inform Assoc 20 2013 603 612
56. A. Bochare, A. Gangopadhyay, Y. Yesha, A. Joshi, Y. Yesha, M. Brady, and et al. Integrating domain knowledge in supervised machine learning to assess the risk of breast cancer Int J Med Eng Inform 6 2014 87 99
57. S. Gilmore, R. Hofmann-Wellenhof, and H.P. Soyer A support vector machine for decision support in melanoma recognition Exp Dermatol 19 2010 830 835
58. N. Mac Parthaláin, and R. Zwiggelaar Machine learning techniques and mammographic risk assessment. Digital mammography 2010 Springer pp. 664-672
59. M.A. Hall Feature selection for discrete and numeric class machine learning 1999
60. R. Kohavi, and G.H. John Wrappers for feature subset selection Artif Intell 97 1997 273 324
61. P.A. Estévez, M. Tesmer, C.A. Perez, and J.M. Zurada Normalized mutual information feature selection IEEE Trans Neural Netw 20 2009 189 201
62. T. Barrett, D.B. Troup, S.E. Wilhite, P. Ledoux, D. Rudnev, C. Evangelista, and et al. NCBI GEO: mining tens of millions of expression profiles - database and tools update Nucleic Acids Res 35 2007 D760 D765
63. Y. Niu, D. Otasek, and I. Jurisica Evaluation of linguistic features useful in extraction of interactions from PubMed; application to annotating known, high-throughput and predicted interactions in I2D Bioinformatics 26 2010 111 119
64. N. Howlader, A. Noone, M. Krapcho, J. Garshell, N. Neyman, and S. Aletkruse SEER Cancer Statistics Review, 1975-2010, [Online] National Cancer Institute 2013 National Cancer Institute Bethesda, MD [Online]
65. X. Bian, J. Klemm, A. Basu, J. Hadfield, R. Srinivasa, T. Parnell, and et al. Data submission and curation for caArray, a standard based microarray data repository system 2009
66. A. Papadopoulos, D.I. Fotiadis, and L. Costaridou Improvement of microcalcification cluster detection in mammography utilizing image enhancement techniques Comput Biol Med 38 2008 1045 1055
67. A. Papadopoulos, D.I. Fotiadis, and A. Likas Characterization of clustered microcalcifications in digitized mammograms using neural networks and support vector machines Artif Intell Med 34 2005 141 150
68. E. Bilal, J. Dutkowski, J. Guinney, I.S. Jang, B.A. Logsdon, G. Pandey, and et al. Improving breast cancer survival analysis through competition-based multidimensional modeling PLoS Comput Biol 9 2013 e1003047
69. J. Cuzick, M. Dowsett, S. Pineda, C. Wale, J. Salter, E. Quinn, and et al. Prognostic value of a combined estrogen receptor, progesterone receptor, Ki-67, and human epidermal growth factor receptor 2 immunohistochemical score and comparison with the Genomic Health recurrence score in early breast cancer J Clin Oncol 29 2011 4273 4278
70. J.S. Parker, M. Mullins, M.C. Cheang, S. Leung, D. Voduc, T. Vickery, and et al. Supervised risk predictor of breast cancer based on intrinsic subtypes J Clin Oncol 27 2009 1160 1167
71. S. Paik, S. Shak, G. Tang, C. Kim, J. Baker, M. Cronin, and et al. A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer N Engl J Med 351 2004 2817 2826